Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020

SELL
$29.79 - $43.06 $56,213 - $81,254
-1,887 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$30.47 - $37.65 $27,240 - $33,659
894 Added 90.03%
1,887 $61,000
Q2 2019

Aug 14, 2019

BUY
$25.73 - $35.79 $25,549 - $35,539
993 New
993 $35,000

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.62B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Shen Neil Nanpeng Portfolio

Follow Shen Neil Nanpeng and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shen Neil Nanpeng, based on Form 13F filings with the SEC.

News

Stay updated on Shen Neil Nanpeng with notifications on news.